BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Merck & Co., Inc. (MRK) May Not Have Shown Women Can Safely Choose Drug


11/7/2012 8:04:05 AM

Merck & Co. (MRK) may not have shown that women can safely choose to use the company’s overactive-bladder medication Oxytrol without a doctor’s prescription, U.S. regulators said. Food and Drug Administration staff asked outside advisers to vote on whether Merck’s data supports that women can appropriately choose to use the patch in an over-the-counter setting. The FDA staff released its report today ahead of a Nov. 9 advisory panel meeting to discuss the drug, which Merck is seeking to make the first bladder treatment available without a prescription. Merck, the third-largest U.S. drugmaker by revenue, bought the rights to nonprescription Oxytrol from Watson Pharmaceuticals Inc. (WPI) The FDA is scheduled to decide on Merck’s Oxytrol by the end of January, said Edwin Hemwall, associate vice president of clinical research for prescription to over- the-counter switches at the Whitehouse Station, New Jersey-based company.

Read at Bloomberg

Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES